| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/07/2001 | CA2491610A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491433A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2491258A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490909A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2490853A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2397731A1 Immunogen antivenom and vaccine against the venom of the black widow sp ider |
| 06/07/2001 | CA2395055A1 Exson-intron junction determining device, genetic region determining device, and determining method for them |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2394254A1 Surface modified supporting materials for binding biological materials, method for the production and use thereof |
| 06/07/2001 | CA2394142A1 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 06/07/2001 | CA2394016A1 Novel endoplasmic localization proteins,therapeutic agents for glycoprotein aberration disorders containing same,dna encoding the proteins,and therapeutic agents in gene therapy for glycoprotein aberration disorders |
| 06/07/2001 | CA2393369A1 Human cytokine receptor |
| 06/07/2001 | CA2393360A1 Targeted methods of drug screening using co-culture methods |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2393136A1 Evaluating and predicting clinical outcomes by gene expression analysis |
| 06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392981A1 Direct screening method |
| 06/07/2001 | CA2392963A1 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 06/07/2001 | CA2392959A1 Preparation of sequence libraries from non-denatured rna and kits therefor |
| 06/07/2001 | CA2392958A1 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392946A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | CA2392941A1 Drug inducible system and use thereof |
| 06/07/2001 | CA2392939A1 Naive screening method |
| 06/07/2001 | CA2392933A1 Cryptosporidium sporozoite antigens |
| 06/07/2001 | CA2392906A1 Pseudomonas aeruginosa antigens |
| 06/07/2001 | CA2392895A1 Streptococcus pneumoniae antigens |
| 06/07/2001 | CA2392853A1 Hbv sequences |
| 06/07/2001 | CA2392805A1 Dna fragment having promoter activity |
| 06/07/2001 | CA2392729A1 Human antibodies as detection reagents |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
| 06/07/2001 | CA2392537A1 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | CA2392534A1 Method and apparatus for selectively targeting specific cells within a cell population |
| 06/07/2001 | CA2392111A1 Biological control by conditional dominant lethal genetic system |
| 06/07/2001 | CA2391455A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | CA2391404A1 Udp-glucose:aglycon-glucosyltransferase |
| 06/07/2001 | CA2391402A1 Masp-3, a complement-fixing enzyme, and uses for it |
| 06/07/2001 | CA2391312A1 Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2390088A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | CA2389262A1 Modified il-12 subunits and nucleic acids encoding them |
| 06/07/2001 | CA2388538A1 Bacillus thuringiensis toxin active against formicidae (ant) |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | CA2360342A1 Generation of single-strand circular dna from linear self-annealing segments |
| 06/06/2001 | EP1104887A2 A method and test kit for assaying collagen fragments in body fluids |
| 06/06/2001 | EP1104814A2 Method for predicting risk of developing chronic pulmonary emphysema |
| 06/06/2001 | EP1104813A1 Conditional replication of recombinant human adenovirus DNA carrying modified inverted terminal repeat sequences |
| 06/06/2001 | EP1104812A1 Nucleotide sequences coding for the gpm gene |
| 06/06/2001 | EP1104811A1 HBV sequences |
| 06/06/2001 | EP1104810A1 Method for the fermentative production of L-lysine using coryneform bacteria |
| 06/06/2001 | EP1104809A1 Process for producing alpha-interferon |
| 06/06/2001 | EP1104808A1 ESTs and encoded human proteins |
| 06/06/2001 | EP1104807A2 Apparatus for the production of TGF-beta |
| 06/06/2001 | EP1104771A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| 06/06/2001 | EP1104769A2 Modified green fluorescent proteins |
| 06/06/2001 | EP1104687A2 Nucleic acid-immobilized substrate |
| 06/06/2001 | EP1104676A1 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/06/2001 | EP1104492A1 Subtle mitochondrial mutations as tumor markers |
| 06/06/2001 | EP1104490A1 Method of detecting a dna sequence, a dna sequence, a method of making a dna construct and the use thereof |
| 06/06/2001 | EP1104489A1 Method for separating and characterising functions potentially present in a biological sample containing nucleic acids |
| 06/06/2001 | EP1104488A1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/06/2001 | EP1104483A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/06/2001 | EP1104481A2 Plant expression vectors |
| 06/06/2001 | EP1104480A1 Polynucleotide sequences |
| 06/06/2001 | EP1104479A2 Method for recovering proteins from the interstitial fluid of plant tissues |
| 06/06/2001 | EP1104478A1 Reduction of bowman-birk protease inhibitor levels in plants |
| 06/06/2001 | EP1104477A1 Increasing stearate content in soybean oil by expression of acyl-acp thioesterase |
| 06/06/2001 | EP1104476A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
| 06/06/2001 | EP1104475A1 C-myc is activated by beta-catenin and tcf-4 |
| 06/06/2001 | EP1104474A1 Dna constructs comprising protease encoding sequences or inhibitors thereof |
| 06/06/2001 | EP1104473A2 Proteases and associated proteins |
| 06/06/2001 | EP1104472A1 Gene switch |
| 06/06/2001 | EP1104471A2 Pesticidal toxins and genes from bacillus laterosporus strains |
| 06/06/2001 | EP1104470A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/06/2001 | EP1104469A1 Seed-preferred promoters |
| 06/06/2001 | EP1104468A1 Genetic method for the expression of polyproteins in plants |
| 06/06/2001 | EP1104467A2 Pc4 transcriptional coactivators |
| 06/06/2001 | EP1104466A1 Leptin-related peptides |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 06/06/2001 | EP1104463A1 Role of human kis (hkis) as an inhibitory kinase of the cyclin-dependent kinase inhibitor p27. compositions, methods and uses thereof to control cell proliferation |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 06/06/2001 | EP1104461A1 Grip, human adapter protein related to the grb2 family member |
| 06/06/2001 | EP1104460A1 Modulation of apoptosis with bid |
| 06/06/2001 | EP1104459A1 Dna shuffling of monooxygenase genes for production of industrial chemicals |
| 06/06/2001 | EP1104458A1 Methods for purifying non-chromosomal nucleic acid molecules from cells |
| 06/06/2001 | EP1104457A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
| 06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104405A1 Near infrared chemiluminescent acridinium compounds and uses thereof |
| 06/06/2001 | EP1104326A1 Apparatus and method for the delivery of drugs and genes into tissue |